Key facts
- It has raised $2.7M; the latest was Early Stage VC in Dec 2024.
- Notable investors include Enterprise Ireland, NLC Health Ventures, Castanjo BV, Spark Venture Crowdfunding.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Altach
- ·The full record, as it builds
Funding rounds
No funding rounds for Altach are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Altach
Developr of biomimetic cartilage scaffolds designed to be used stand-alone and in conjunction with other cell-based therapies. The company utilizes type II collagen which is the building block of native cartilage that creates a matrix for the patient's cells to migrate into and regenerate the cartilage, enabling surgeons to repair cartilage defects and restore patients' quality of life.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2022
- Employees
- 2
- Website
- altach.health/
- Ownership
- Privately Held (backing)
Altach doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Altach shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Altach in its N-PORT filings yet. We sweep new filings monthly.